MA25347A1 - Composition du lypoglycan et methodes de traitement des infections d'origines parasites. - Google Patents
Composition du lypoglycan et methodes de traitement des infections d'origines parasites.Info
- Publication number
- MA25347A1 MA25347A1 MA26327A MA26327A MA25347A1 MA 25347 A1 MA25347 A1 MA 25347A1 MA 26327 A MA26327 A MA 26327A MA 26327 A MA26327 A MA 26327A MA 25347 A1 MA25347 A1 MA 25347A1
- Authority
- MA
- Morocco
- Prior art keywords
- composition
- lypoglycan
- methods
- treating infections
- origins
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
- C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
- C08B37/006—Heteroglycans, i.e. polysaccharides having more than one sugar residue in the main chain in either alternating or less regular sequence; Gellans; Succinoglycans; Arabinogalactans; Tragacanth or gum tragacanth or traganth from Astragalus; Gum Karaya from Sterculia urens; Gum Ghatti from Anogeissus latifolia; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/0003—Invertebrate antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/002—Protozoa antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/10—Anthelmintics
- A61P33/12—Schistosomicides
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
- C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S435/00—Chemistry: molecular biology and microbiology
- Y10S435/975—Kit
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Organic Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Tropical Medicine & Parasitology (AREA)
- Microbiology (AREA)
- Materials Engineering (AREA)
- Immunology (AREA)
- Polymers & Plastics (AREA)
- Mycology (AREA)
- Epidemiology (AREA)
- Molecular Biology (AREA)
- Engineering & Computer Science (AREA)
- Biochemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Polysaccharides And Polysaccharide Derivatives (AREA)
- Saccharide Compounds (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US12393199P | 1999-03-12 | 1999-03-12 |
Publications (1)
Publication Number | Publication Date |
---|---|
MA25347A1 true MA25347A1 (fr) | 2001-12-31 |
Family
ID=22411778
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MA26327A MA25347A1 (fr) | 1999-03-12 | 2001-09-12 | Composition du lypoglycan et methodes de traitement des infections d'origines parasites. |
Country Status (17)
Country | Link |
---|---|
US (3) | US6428793B1 (fr) |
EP (1) | EP1175226B1 (fr) |
JP (1) | JP2002538220A (fr) |
AT (1) | ATE439857T1 (fr) |
AU (1) | AU771373B2 (fr) |
BR (1) | BR0008949A (fr) |
CA (1) | CA2364507A1 (fr) |
DE (1) | DE60042776D1 (fr) |
HU (1) | HUP0200466A3 (fr) |
MA (1) | MA25347A1 (fr) |
MX (1) | MXPA01009206A (fr) |
NO (1) | NO20014411L (fr) |
NZ (1) | NZ514112A (fr) |
PL (1) | PL203789B1 (fr) |
TR (3) | TR200202066T2 (fr) |
WO (1) | WO2000053220A1 (fr) |
ZA (1) | ZA200107502B (fr) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6756361B1 (en) * | 1997-10-14 | 2004-06-29 | Nabi | Enterococcus antigens and vaccines |
US7164520B2 (en) | 2004-05-12 | 2007-01-16 | Idc, Llc | Packaging for an interferometric modulator |
WO2006041613A2 (fr) * | 2004-10-05 | 2006-04-20 | Nanomega Medical Corporation | Nanoparticules destinees au traitement de cellules hepatomes |
EP2490707B1 (fr) | 2009-10-21 | 2016-07-27 | ETH Zurich | Utilité médicale des protéines liant les glycanes et des glycanes |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2598147B1 (fr) * | 1986-04-30 | 1988-08-26 | Pasteur Institut | Immunogene isole de mollusques, son procede de preparation, reactifs de diagnostic des bilharzioses humaines, vaccins contre les schistosomiases et compositions immunisantes comprenant ledit immunogene. |
FR2601021B2 (fr) * | 1986-07-07 | 1988-11-18 | Pasteur Institut | Fraction immunogene active a l'egard des bilharzioses, sa preparation, compositions immunisantes la contenant |
US5280113A (en) * | 1989-08-16 | 1994-01-18 | Monsanto Company | Method for producing synthetic N-linked glycoconjugates |
US5212298A (en) | 1989-08-16 | 1993-05-18 | Monsanto Company | Method for producing synthetic N-linked glycoconjugates |
US5679347A (en) * | 1992-12-10 | 1997-10-21 | Brigham And Women's Hospital | Methods of isolating CD1-presented antigens, vaccines comprising CD1-presented antigens, and cell lines for use in said methods |
US5541075A (en) * | 1993-02-05 | 1996-07-30 | Heska Corporation | Carbohydrate-based vaccine and diagnostic reagent for trichinosis |
BR9305075A (pt) * | 1993-12-16 | 1995-08-08 | Fundacao Oswaldo Cruz | Antígeno para conferir imunidade protetora contra infecções helmínticas em humanos e animais,e processo de vacinação para aplicação na imunoprofilaxia de doenças helmintológicas de interesse veterinário e médico |
AU5928999A (en) * | 1998-09-21 | 2000-04-10 | Richard D. Cummings | Assays for helminth infections |
-
2000
- 2000-03-10 HU HU0200466A patent/HUP0200466A3/hu unknown
- 2000-03-10 PL PL350989A patent/PL203789B1/pl not_active IP Right Cessation
- 2000-03-10 CA CA002364507A patent/CA2364507A1/fr not_active Abandoned
- 2000-03-10 US US09/523,404 patent/US6428793B1/en not_active Expired - Lifetime
- 2000-03-10 NZ NZ514112A patent/NZ514112A/en not_active IP Right Cessation
- 2000-03-10 TR TR2002/02066T patent/TR200202066T2/xx unknown
- 2000-03-10 TR TR2001/03231T patent/TR200103231T2/xx unknown
- 2000-03-10 JP JP2000603709A patent/JP2002538220A/ja active Pending
- 2000-03-10 AT AT00914930T patent/ATE439857T1/de not_active IP Right Cessation
- 2000-03-10 EP EP00914930A patent/EP1175226B1/fr not_active Expired - Lifetime
- 2000-03-10 MX MXPA01009206A patent/MXPA01009206A/es active IP Right Grant
- 2000-03-10 DE DE60042776T patent/DE60042776D1/de not_active Expired - Fee Related
- 2000-03-10 WO PCT/US2000/006404 patent/WO2000053220A1/fr active IP Right Grant
- 2000-03-10 AU AU36251/00A patent/AU771373B2/en not_active Ceased
- 2000-03-10 TR TR2002/02078T patent/TR200202078T2/xx unknown
- 2000-03-10 BR BR0008949-4A patent/BR0008949A/pt not_active IP Right Cessation
-
2001
- 2001-09-11 NO NO20014411A patent/NO20014411L/no not_active Application Discontinuation
- 2001-09-11 ZA ZA200107502A patent/ZA200107502B/xx unknown
- 2001-09-12 MA MA26327A patent/MA25347A1/fr unknown
-
2002
- 2002-06-17 US US10/174,130 patent/US7063848B2/en not_active Expired - Fee Related
-
2006
- 2006-04-27 US US11/412,773 patent/US7204983B2/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
TR200202066T2 (tr) | 2004-12-21 |
NZ514112A (en) | 2003-08-29 |
BR0008949A (pt) | 2002-09-24 |
US20020160021A1 (en) | 2002-10-31 |
HUP0200466A2 (en) | 2002-06-29 |
MXPA01009206A (es) | 2003-07-14 |
JP2002538220A (ja) | 2002-11-12 |
US6428793B1 (en) | 2002-08-06 |
AU771373B2 (en) | 2004-03-18 |
DE60042776D1 (de) | 2009-10-01 |
PL203789B1 (pl) | 2009-11-30 |
US20060228382A1 (en) | 2006-10-12 |
TR200202078T2 (tr) | 2002-11-21 |
ZA200107502B (en) | 2003-02-26 |
ATE439857T1 (de) | 2009-09-15 |
AU3625100A (en) | 2000-09-28 |
WO2000053220A1 (fr) | 2000-09-14 |
HUP0200466A3 (en) | 2006-11-28 |
US7063848B2 (en) | 2006-06-20 |
EP1175226A4 (fr) | 2005-01-05 |
EP1175226B1 (fr) | 2009-08-19 |
PL350989A1 (en) | 2003-02-24 |
EP1175226A1 (fr) | 2002-01-30 |
US7204983B2 (en) | 2007-04-17 |
TR200103231T2 (tr) | 2002-03-21 |
NO20014411D0 (no) | 2001-09-11 |
NO20014411L (no) | 2001-11-09 |
CA2364507A1 (fr) | 2000-09-14 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE195740T1 (de) | Glucosamin-disaccharide, verfahren zu deren herstellung, pharmazeutische präparate davon und ihre verwendung | |
GR3032037T3 (en) | Immunogen compounds having specifically an anti-cytokine effect, method of preparation, pharmaceutical compositions and kits containing them | |
MX9301706A (es) | Composicion de vacuna para el tratamiento de la infeccion por helicobacter. | |
UA40597C2 (uk) | Вакцинна композиція,спосіб лікування ссавців, що страждають або сприйнятливі до інфекції, спосіб лікування ссавців, що страждають на рак, спосіб одержання вакцинної композиції, композиція ад'ювантів | |
PT98710A (pt) | Processo de preparacao de compostos de indolilo substituidos e de composicoes farmaceuticas que os contem | |
DE69534992D1 (de) | Mutierendes enterotoxin als nichttoxisches orales adjuvans | |
AU7877900A (en) | Method of obtaining cellular immune responses from proteins | |
PT760649E (pt) | Formulacoes a base de propionato de fluticasona | |
BR9507400A (pt) | Composições imunogénicas de polissacaridio streptococal grupo a e processos | |
PT692028E (pt) | Farmacos baseados em papilomavirus | |
IT1179444B (it) | Composizione farmaceutica a base di estratto solubile in piridina e di endotossina detossicata raffinata e suo impiego | |
ATE124265T1 (de) | Idiotypen-impfung gegen b-zell-lymphoma. | |
IL161889A0 (en) | Method for treating diseases with omega interferon | |
ES2188788T3 (es) | Bi-heteroarilmetoxifenilalquil carboxilatos simetricos que inhiben la biosintesis de leucotrieno. | |
KR890701099A (ko) | 기침 및 기관지 협착을 치료하기 위한 5-ht3 수용기 길항물질 | |
MA25347A1 (fr) | Composition du lypoglycan et methodes de traitement des infections d'origines parasites. | |
AU5673399A (en) | Compositions and methods for treating intracellular infections | |
BR9814432A (pt) | Composições derivadas de mycobacterium vaccae e processo para seu uso | |
NO20023102L (no) | Fremgangsmåte og formulering for behandling av residens mot anti-hypertensiver og relaterte tilstander | |
CA2225788A1 (fr) | Agents therapeutiques pour maladies auto-immunes | |
EP1131338A4 (fr) | Procede de production de proteine invasine hautement purifiee et utilisation de cette proteine | |
PT94030A (pt) | Processo de preparacao de antigenios protectores contra as infeccoes e efeitos toxidos de bordetella | |
DE60045516D1 (de) | Pflanzen lektine als mukosale adjuvantien | |
PT793666E (pt) | Processo de sililacao | |
BR0003648A (pt) | Composições e métodos para tratar condições alérgicas e inflamatórias com tosse |